• Home
• About EECP Therapy...
• About EECP
• Medical Background
• Costs
• How it works
• Before & After
• Avoid By-Pass Surgery
• Testimonials
• References & Information
  • Clinical Studies/Articles
  • Journals
  • Exercise Tolerance
  • Abstracts
• About Primary Heart Care
• About Us
• Contact Us

About EECP

Is EECP for you?

These and many more are symptoms or warning signs and a course of EECP can really benefit and help you get your life back where it should be.

EECP is said to be a natural bypass because it can stimulate production of a hormone called vascular endothelial growth factor (VEGF). EECP can enhance secretion of a vasodilator called nitrous oxide. Because of the increased levels of VEGF and nitrous oxide, these collaterals become larger and wider. With the increased flow of oxygen-rich blood through- out the body, your heart and all other organs improve their function.

INDICATIONS FOR USE

Enhanced external counterpulsation therapy systems are noninvasive external counterpulsation devices intended for use in the treatment of patients with stable or unstable angina, congestive heart failure, acute myocardial infarction, or cardiogenic shock.

CONTRAINDICATIONS

• Arrhythmias that interfere with machine triggering
• Bleeding diathesis
• Active thrombophlebitis
• Severe lower extremity vaso-occlusive disease
• Presence of a documented aortic aneurysm requiring surgical repair
• Pregnancy

PRECAUTIONS

Patients with blood pressure higher than 180/110 mmHg should be controlled prior to treatment with enhanced external counter pulsation

Patients with a heart rate more than 120 bpm should be controlled prior to treatment with enhanced external counter pulsation

Patients at high risk of complications from increased venous return should be carefully chosen and monitored during treatment with enhanced external counter pulsation. Decreasing cardiac after load by optimizing diastolic augmentation may help minimize increased cardiac filling pressures due to venous return.

Patients with clinically significant valvular disease should be carefully chosen and monitored during treatment with enhanced external counter pulsation. Certain valve conditions, such as significant aortic insufficiency, or severe mitral or aortic stenosis, may prevent the patient from obtaining benefit from diastolic augmentation and reduced cardiac after load in the presence of increased venous return.

For further understanding of patient selection criteria please contact your heart specialist or call us to make an appointment to discuss your options.